Welcome to LookChem.com Sign In|Join Free

CAS

  • or
L-5-Hydroxytryptophan, also known as 5-Hydroxy-L-tryptophan, is a hydroxylated metabolite of L-tryptophan, an essential amino acid. It plays a crucial role in the biosynthesis of various neurotransmitters and hormones, particularly serotonin, which is vital for regulating mood, appetite, and sleep.

4350-09-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4350-09-8 Structure
  • Basic information

    1. Product Name: L-5-Hydroxytryptophan
    2. Synonyms: 5-hydroxy-l-tryptopha;pretonine;C5-HYDROXY-L-TRYPTOPHAN;H-5-HYDROXY-TRP-OH;H-TRP(5-OH)-OH;L-2-AMINO-3-(5-HYDROXYINDOLYL)PROPIONIC ACID;L-5-HYDROXYTRYPTOPHAN HYDRATE;L-5-HYDROXYTRYPTOPHAN
    3. CAS NO:4350-09-8
    4. Molecular Formula: C11H12N2O3
    5. Molecular Weight: 220.22
    6. EINECS: 224-411-1
    7. Product Categories: Pharmaceutical Raw Materials;Indoles and derivatives;Tryptophan [Trp, W];Amino Acids;Biochemistry;Biological-modified Amino Acids;Indoles;Tryptophans;Natural Plant Extract;Amino acidsPeptide Synthesis;Biochemicals Found in Plants;Nutrition Research;Tryptophan Derivatives;Unnatural Amino Acid Derivatives;Amines;Heterocycles;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Metabolites & Impurities;Pharmaceuticals;Amines, Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals;amino;Other APIs;natural product;Inhibitors
    8. Mol File: 4350-09-8.mol
  • Chemical Properties

    1. Melting Point: 270 °C (dec.)(lit.)
    2. Boiling Point: 361.16°C (rough estimate)
    3. Flash Point: 175 °F
    4. Appearance: white/solid
    5. Density: 0.902 g/mL at 25 °C(lit.)
    6. Refractive Index: n20/D 1.4850(lit.)
    7. Storage Temp.: 2-8°C
    8. Solubility: H2O: 10 mg/mL
    9. PKA: 2.22±0.10(Predicted)
    10. Water Solubility: Slightly soluble
    11. Merck: 14,4847
    12. BRN: 88200
    13. CAS DataBase Reference: L-5-Hydroxytryptophan(CAS DataBase Reference)
    14. NIST Chemistry Reference: L-5-Hydroxytryptophan(4350-09-8)
    15. EPA Substance Registry System: L-5-Hydroxytryptophan(4350-09-8)
  • Safety Data

    1. Hazard Codes: Xn,Xi
    2. Statements: 22-36/37/38-65-20/21/22-20/21
    3. Safety Statements: 36-26
    4. RIDADR: UN 2811 6.1/PG 3
    5. WGK Germany: 3
    6. RTECS: YN7110000
    7. F: 3-10
    8. TSCA: Yes
    9. HazardClass: 6.1
    10. PackingGroup: III
    11. Hazardous Substances Data: 4350-09-8(Hazardous Substances Data)

4350-09-8 Usage

Uses

Used in Research and Development:
L-5-Hydroxytryptophan is used as a precursor of 5-hydroxytryptamine (serotonin) for experimental purposes, such as injecting experimental mice to study serotonin detection and its effects on various physiological processes.
Used in Prenatal and Neonatal Studies:
L-5-Hydroxytryptophan is used as a precursor in pregnant mice and neonatal rats for vital neutral red staining of lung slices, aiding researchers in understanding the development and function of the respiratory system in these subjects.
Used in Analytical Chemistry:
L-5-Hydroxytryptophan serves as a standard in citrate-acetate buffer for its use in high-performance liquid chromatography (HPLC) analysis, enabling accurate quantification and identification of related compounds in various samples.

Air & Water Reactions

L-5-Hydroxytryptophan is sensitive to air. Slightly water soluble .

Reactivity Profile

L-5-Hydroxytryptophan reacts with bases. .

Fire Hazard

Flash point data for L-5-Hydroxytryptophan are not available, however, L-5-Hydroxytryptophan is probably combustible.

Biochem/physiol Actions

Hydroxylation of L-tryptophan occurs in the brain during serotonin synthesis. This is a step that controls the production of serotonin and also yields 5-hydroxy-l-tryptophan (5-HTP) as a metabolite. Thus, consumption 5-HTP, increases the serotonin level, which might result in depression, lack of sleep and severe headache.

Purification Methods

Likely impurities are 5-hydroxy-D-tryptophan and 5-benzyloxytryptophan. Crystallise 5-hydroxy-L-tryptophan under nitrogen from water by adding EtOH. Store it under nitrogen. Also dissolve it in the minimum volume of hot H2O (~0.7g in 4mL) under nitrogen (charcoal) and allowed it to crystallise at 5o. The picrolonate crystallises from H2O with m 184-186o(dec). [Greenstein & Winitz The Chemistry of the Amino Acids J. Wiley, Vol 3 p 2732-2737 1961, Morris & Armstrong J Org Chem 22 306 1957, Beilstein 22/14 V 278.]

Check Digit Verification of cas no

The CAS Registry Mumber 4350-09-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,5 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4350-09:
(6*4)+(5*3)+(4*5)+(3*0)+(2*0)+(1*9)=68
68 % 10 = 8
So 4350-09-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)

4350-09-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0531)  5-Hydroxy-L-tryptophan  >98.0%(HPLC)(T)

  • 4350-09-8

  • 1g

  • 230.00CNY

  • Detail
  • TCI America

  • (H0531)  5-Hydroxy-L-tryptophan  >98.0%(HPLC)(T)

  • 4350-09-8

  • 5g

  • 740.00CNY

  • Detail
  • Alfa Aesar

  • (A13954)  L-5-Hydroxytryptophan hydrate, 98%   

  • 4350-09-8

  • 0.25g

  • 177.0CNY

  • Detail
  • Alfa Aesar

  • (A13954)  L-5-Hydroxytryptophan hydrate, 98%   

  • 4350-09-8

  • 1g

  • 328.0CNY

  • Detail
  • Alfa Aesar

  • (A13954)  L-5-Hydroxytryptophan hydrate, 98%   

  • 4350-09-8

  • 5g

  • 1390.0CNY

  • Detail
  • Sigma

  • (H9772)  5-Hydroxy-L-tryptophan  powder

  • 4350-09-8

  • H9772-100MG

  • 402.48CNY

  • Detail
  • Sigma

  • (H9772)  5-Hydroxy-L-tryptophan  powder

  • 4350-09-8

  • H9772-250MG

  • 617.76CNY

  • Detail
  • Sigma

  • (H9772)  5-Hydroxy-L-tryptophan  powder

  • 4350-09-8

  • H9772-1G

  • 1,048.32CNY

  • Detail
  • Sigma

  • (H9772)  5-Hydroxy-L-tryptophan  powder

  • 4350-09-8

  • H9772-5G

  • 4,214.34CNY

  • Detail
  • Sigma

  • (H9772)  5-Hydroxy-L-tryptophan  powder

  • 4350-09-8

  • H9772-25G

  • 7,318.35CNY

  • Detail
  • Aldrich

  • (107751)  5-Hydroxy-L-tryptophan  98% (calc. on dried substance)

  • 4350-09-8

  • 107751-1G

  • 260.91CNY

  • Detail
  • USP

  • (1329913)  5-Hydroxy-L-tryptophan  United States Pharmacopeia (USP) Reference Standard

  • 4350-09-8

  • 1329913-100MG

  • 4,647.24CNY

  • Detail

4350-09-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-hydroxy-L-tryptophan

1.2 Other means of identification

Product number -
Other names L-Tryptophan, 5-hydroxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4350-09-8 SDS

4350-09-8Synthetic route

indol-5-ol
1953-54-4

indol-5-ol

L-serin
56-45-1

L-serin

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
Stage #1: indol-5-ol; L-serin With pyridoxal 5'-phosphate; thermotoga maritima with tryptophan synthase β-subunit from pyrococcus furiosus M145T N167D mutant In aq. phosphate buffer; water; dimethyl sulfoxide at 75℃; for 2h; pH=8; Sealed tube; Enzymatic reaction;
Stage #2: With hydrogenchloride In water
93%
With transformed Escherichia coli cells at 37℃; for 24h;70 % Chromat.
With tryptophan synthase; pyridoxal 5'-phosphate at 37℃; for 24h; pH=7.8; Enzymatic reaction;
DL-5-hydroxytryptophane amide
90830-06-1

DL-5-hydroxytryptophane amide

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
43%
43%
L-Tryptophan
73-22-3

L-Tryptophan

A

7-Hydroxy-L-tryptophan
25198-02-1

7-Hydroxy-L-tryptophan

B

4-Hydroxy-L-tryptophan
25242-90-4

4-Hydroxy-L-tryptophan

C

(S)-6-hydroxytryptophan
13567-14-1

(S)-6-hydroxytryptophan

D

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
With dihydrogen peroxide; edetate disodium; iron(II) sulfate; ascorbic acid In water at 22℃; for 0.0416667h;A n/a
B 10%
C n/a
D 12%
L-N-benzyloxycarbonyl-5-benzyloxytryptophan
3520-59-0

L-N-benzyloxycarbonyl-5-benzyloxytryptophan

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
With ethanol; palladium Hydrogenation;
5-benzyloxy-Nα-benzyloxycarbonyl-DL-tryptophan
3017-27-4

5-benzyloxy-Nα-benzyloxycarbonyl-DL-tryptophan

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: quinine
2: palladium; ethanol / Hydrogenation
View Scheme
L-Tryptophan
73-22-3

L-Tryptophan

A

tryptamine
61-54-1

tryptamine

B

L-kynurenine
2922-83-0

L-kynurenine

C

hydroxyhexahydropyrrolo[2,3-b]indole-2-carboxylic acid

hydroxyhexahydropyrrolo[2,3-b]indole-2-carboxylic acid

D

(S )-2-Amino-4-(2-formamidophenyl)-4-oxobutanoic acid

(S )-2-Amino-4-(2-formamidophenyl)-4-oxobutanoic acid

E

hydroxyoxoindolylalanine

hydroxyoxoindolylalanine

F

2-amino-3-(2-oxoindolin-3-yl)propanoic acid
236094-74-9

2-amino-3-(2-oxoindolin-3-yl)propanoic acid

G

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
With dihydrogen peroxide at 37℃; for 6h; pH=4.6; Darkness; aq. borate buffer;
L-Tryptophan
73-22-3

L-Tryptophan

L-5-HTP
4350-09-8

L-5-HTP

Conditions
ConditionsYield
With tryptophan hydroxylase Enzymatic reaction;
With ferrous ammonium sulphate; 6-methyl-5,6,7,8-tetrahydrobopterin; tryptophan hydroxylase; oxygen In aq. buffer at 20℃; for 0.333333h; pH=7.7; Kinetics; Mechanism; Catalytic behavior; Reagent/catalyst; Solvent; Temperature; Enzymatic reaction; chemoselective reaction;
methanol
67-56-1

methanol

L-5-HTP
4350-09-8

L-5-HTP

5-hydroxy-DL-tryptophan methyl ester hydrochloride

5-hydroxy-DL-tryptophan methyl ester hydrochloride

Conditions
ConditionsYield
With thionyl chloride at -5 - 20℃; for 16h;98%
With thionyl chloride at 0 - 20℃; Inert atmosphere;74%
L-5-HTP
4350-09-8

L-5-HTP

3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

Conditions
ConditionsYield
With pyridoxal 5'-phosphate; aromatic L-amino acid decarboxylase In various solvent(s) at 30℃; for 48h;97%
With NH4OH-NH4Cl buffer; pyridoxal 5'-phosphate at 30℃; for 0.5h; relative rate of CO2 evolution by aromatic L-amino acid decarboxylase from Micrococcus percitreus;
With isopropyl β-D-thiogalactoside; L-tryptophan decarboxylase in recombinant Escherichia coli at 28℃;
9-methoxy-9-BBN
38050-71-4

9-methoxy-9-BBN

L-5-HTP
4350-09-8

L-5-HTP

C19H25BN2O3

C19H25BN2O3

Conditions
ConditionsYield
With pyridine97%
methanol
67-56-1

methanol

L-5-HTP
4350-09-8

L-5-HTP

2-amino-3-(5-hydroxy-1H-indol-3-yl)propionic acid methyl ester
79812-02-5

2-amino-3-(5-hydroxy-1H-indol-3-yl)propionic acid methyl ester

Conditions
ConditionsYield
With thionyl chloride at 0 - 40℃; for 10h;95%
With thionyl chloride at -5 - 35℃; for 5h;92.9%
With hydrogenchloride at 0 - 20℃; for 18h; Fischer esterification;
copper(ll) bromide
7789-45-9

copper(ll) bromide

L-5-HTP
4350-09-8

L-5-HTP

[copper(II)(L-5-hydroxytryptophan)2(bromide)2] monohydrate

[copper(II)(L-5-hydroxytryptophan)2(bromide)2] monohydrate

Conditions
ConditionsYield
In methanol for 3h; Reflux;89%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(3,4-dichlorophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(3,4-dichlorophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 2.5h;89%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

L-5-HTP
4350-09-8

L-5-HTP

(S)-2-tert-butoxycarbonylamino-3-(5-tert-butoxycarbonyloxy-1H-indol-3-yl)propionic acid
390816-59-8

(S)-2-tert-butoxycarbonylamino-3-(5-tert-butoxycarbonyloxy-1H-indol-3-yl)propionic acid

Conditions
ConditionsYield
With potassium hydroxide In isopropyl alcohol for 5h; pH=11.5 - 12.0;87%
nickel(II) bromide trihydrate

nickel(II) bromide trihydrate

L-5-HTP
4350-09-8

L-5-HTP

[nickel(II)(L-5-hydroxytryptophan)2(methanol)2(bromide)2]

[nickel(II)(L-5-hydroxytryptophan)2(methanol)2(bromide)2]

Conditions
ConditionsYield
In methanol for 3h; Reflux;86%
2,6-difluorophenylisothiocyanate
207974-17-2

2,6-difluorophenylisothiocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(2,6-difluorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(2,6-difluorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 3h;85%
2,4-diflurophenylisocyanate
59025-55-7

2,4-diflurophenylisocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(2,4-difluorophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(2,4-difluorophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 4h;85%
copper(II) choride dihydrate

copper(II) choride dihydrate

L-5-HTP
4350-09-8

L-5-HTP

[copper(II)(L-5-hydroxytryptophan)2(chloride)2]

[copper(II)(L-5-hydroxytryptophan)2(chloride)2]

Conditions
ConditionsYield
In methanol for 3h; Reflux;84.8%
nickel(II) nitrate hexahydrate

nickel(II) nitrate hexahydrate

L-5-HTP
4350-09-8

L-5-HTP

[nickel(II)(L-5-hydroxytryptophan)2(nitrate)2] methanol disolvate monohydrate

[nickel(II)(L-5-hydroxytryptophan)2(nitrate)2] methanol disolvate monohydrate

Conditions
ConditionsYield
In methanol for 3h; Reflux;84%
3,4-dichlorophenyl isothiocyanate
6590-94-9

3,4-dichlorophenyl isothiocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(3,4-dichlorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(3,4-dichlorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 4h;83%
cobalt(II) chloride hexahydrate

cobalt(II) chloride hexahydrate

L-5-HTP
4350-09-8

L-5-HTP

[cobalt(II)(L-5-hydroxytryptophan)2(chloride)2] pentahydrate

[cobalt(II)(L-5-hydroxytryptophan)2(chloride)2] pentahydrate

Conditions
ConditionsYield
In methanol for 3h; Reflux;82.8%
cobalt(II) bromide

cobalt(II) bromide

L-5-HTP
4350-09-8

L-5-HTP

[cobalt(II)(L-5-hydroxytryptophan)2(bromide)2]

[cobalt(II)(L-5-hydroxytryptophan)2(bromide)2]

Conditions
ConditionsYield
In methanol for 3h; Reflux;82.6%
nickel(II) chloride hexahydrate

nickel(II) chloride hexahydrate

L-5-HTP
4350-09-8

L-5-HTP

[nickel(II)(L-5-hydroxytryptophan)2(methanol)2(chloride)2] monohydrate

[nickel(II)(L-5-hydroxytryptophan)2(methanol)2(chloride)2] monohydrate

Conditions
ConditionsYield
In methanol for 3h; Reflux;82.6%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

L-5-HTP
4350-09-8

L-5-HTP

[copper(II)(L-5-hydroxytryptophan)2(nitrate)2] monohydrate

[copper(II)(L-5-hydroxytryptophan)2(nitrate)2] monohydrate

Conditions
ConditionsYield
In methanol for 3h; Reflux;82.6%
methanol
67-56-1

methanol

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

L-5-HTP
4350-09-8

L-5-HTP

(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(5-hydroxy-1H-indol-3-yl)propanoate
203736-17-8

(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(5-hydroxy-1H-indol-3-yl)propanoate

Conditions
ConditionsYield
Stage #1: methanol; L-5-HTP With thionyl chloride at 0 - 20℃; for 12h;
Stage #2: di-tert-butyl dicarbonate With triethylamine In dichloromethane at 0 - 20℃; for 6h;
82%
4-bromophenyl isocyanate
2493-02-9

4-bromophenyl isocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(4-bromophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(4-bromophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 3h;82%
3-indolylglyoxal
7269-72-9

3-indolylglyoxal

L-5-HTP
4350-09-8

L-5-HTP

6-hydroxy-1-(1H-indole-3-carbonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
1350653-01-8

6-hydroxy-1-(1H-indole-3-carbonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid

Conditions
ConditionsYield
Stage #1: 3-indolylglyoxal; L-5-HTP With sulfuric acid In water at 20℃; for 10h; Pictet-Spengler cyclisation;
Stage #2: With ammonia In water at 0℃; for 12h; pH=6 - 7;
80%
1-isothiocyanato-3-trifluoromethyl-benzene
1840-19-3

1-isothiocyanato-3-trifluoromethyl-benzene

L-5-HTP
4350-09-8

L-5-HTP

3-(5-hydroxy-1H-indol-3-yl)-2-(3-(3-trifluoromethylphenyl)thioureido)propanoic acid

3-(5-hydroxy-1H-indol-3-yl)-2-(3-(3-trifluoromethylphenyl)thioureido)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 3h;80%
4-fluorophenyl isothiocyanate
1544-68-9

4-fluorophenyl isothiocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(4-fluorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(4-fluorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran79%
3-chloro-4-fluorophenyl isothiocyanate
137724-66-4

3-chloro-4-fluorophenyl isothiocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(3-chloro-4-fluorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(3-chloro-4-fluorophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 4h;79%
3-bromophenyl isothiocyanate
2131-59-1

3-bromophenyl isothiocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(3-bromophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(3-bromophenyl)thioureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 3.5h;78%
zinc dibromide

zinc dibromide

L-5-HTP
4350-09-8

L-5-HTP

[zinc(II)(L-5-hydroxytryptophan)2(bromide)2] monohydrate

[zinc(II)(L-5-hydroxytryptophan)2(bromide)2] monohydrate

Conditions
ConditionsYield
In methanol for 3h; Reflux;77.2%
1,3-dimethylbarbituric acid
769-42-6

1,3-dimethylbarbituric acid

L-5-HTP
4350-09-8

L-5-HTP

5-hydroxy-L-tryptophan 1,3-dimethylbarbituric acid complex

5-hydroxy-L-tryptophan 1,3-dimethylbarbituric acid complex

Conditions
ConditionsYield
In water at 100℃; for 0.5h;77%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

L-5-HTP
4350-09-8

L-5-HTP

(S)-2-((tert-butoxycarbonyl)amino)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid
119768-45-5

(S)-2-((tert-butoxycarbonyl)amino)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran; water at 20℃; for 2h;76%
Stage #1: di-tert-butyl dicarbonate; L-5-HTP With sodium hydrogencarbonate In water at 0 - 35℃; for 24h;
Stage #2: With citric acid In water pH=6;
58.16%
With triethylamine In 1,4-dioxane at 20℃;
[Ru(η(6)-cymene)(acetone)3](CF3SO3)2

[Ru(η(6)-cymene)(acetone)3](CF3SO3)2

trifluoroacetic acid
76-05-1

trifluoroacetic acid

L-5-HTP
4350-09-8

L-5-HTP

[(η6-p-cymene)Ru(η6-5-hydroxytryptophan)](CF3SO3)2*CF3COOH

[(η6-p-cymene)Ru(η6-5-hydroxytryptophan)](CF3SO3)2*CF3COOH

Conditions
ConditionsYield
In trifluoroacetic acid ligand was added to Ru-complex in CF3COOH, stirred for 12 h at 50°C; pptd. with Et2O, dried in vac.; elem. anal.;75%
p-chlorphenylisocyanate
104-12-1

p-chlorphenylisocyanate

L-5-HTP
4350-09-8

L-5-HTP

2-(3-(4-chlorophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

2-(3-(4-chlorophenyl)ureido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

Conditions
ConditionsYield
With pyridine; triethylamine In tetrahydrofuran for 3.5h;75%

4350-09-8Relevant articles and documents

Synthesis of redox-active fluorinated 5-hydroxytryptophans as molecular reporters for biological electron transfer

Ohler, Amanda,Long, Hanna,Ohgo, Kei,Tyson, Kristin,Murray, David,Davis, Amanda,Whittington, Chris,Hvastkovs, Eli G.,Duffy, Liam,Haddy, Alice,Sargent, Andrew L.,Allen, William E.,Offenbacher, Adam R.

supporting information, p. 3107 - 3110 (2021/04/02)

Fluorinated 5-hydroxytryptophans (Fn-5HOWs) were synthesized in gram scale quantities and incorporated into a β-hairpin peptide and the protein azurin. The redox-active Fn-5HOWs exhibit unique radical spectroscopic signatures that expand the function of 5HOW as probes for biological electron transfer.

Biocatalysts from cyanobacterial hapalindole pathway afford antivirulent isonitriles against MRSA

Bunn, Brittney M,Xu, Mizhi,Webb, Chase M,Viswanathan, Rajesh

, (2021/04/26)

Abstract: The emergence of resistance to frontline antibiotics has called for novel strategies to combat serious pathogenic infections. Methicillin-resistant Staphylococcus aureus [MRSA] is one such pathogen. As opposed to traditional antibiotics, bacteriostatic anti-virulent agents disarm MRSA, without exerting pressure, that cause resistance. Herein, we employed a thermophilic Thermotoga maritima tryptophan synthase (TmTrpB1) enzyme followed by an isonitrile synthase and Fe(II)-α-ketoglutarate-dependent oxygenase, in sequence as biocatalysts to produce antivirulent indole vinyl isonitriles. We report on conversion of simple derivatives of indoles to their C3-vinyl isonitriles, as the enzymes employed here demonstrated broader substrate tolerance. In toto, eight distinct L-Tryptophan derived α-amino acids (7) were converted to their bioactive vinyl isonitriles (3) by action of an isonitrile synthase (WelI1) and an Fe(II)-α-ketoglutarate-dependent oxygenase (WelI3) yielding structural variants possessing antivirulence against MRSA. These indole vinyl isonitriles at 10 μg/mL are effective as antivirulent compounds against MRSA, as evidenced through analysis of rabbit blood hemolysis assay. Based on a homology modelling exercise, of enzyme-substrate complexes, we deduced potential three dimensional alignments of active sites and glean mechanistic insights into the substrate tolerance of the Fe(II)-α-ketoglutarate-dependent oxygenase. Graphic abstract: [Figure not available: see fulltext.]

Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions

Blei, Felix,Baldeweg, Florian,Fricke, Janis,Hoffmeister, Dirk

, p. 10028 - 10031 (2018/07/29)

Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is the main alkaloid of the fungal genus Psilocybe, the so-called “magic mushrooms.” The pharmaceutical interest in this psychotropic natural product as a future medication to treat depression and anxiety is strongly re-emerging. Here, we present an enhanced enzymatic route of psilocybin production by adding TrpB, the tryptophan synthase of the mushroom Psilocybe cubensis, to the reaction. We capitalized on its substrate flexibility and show psilocybin formation from 4-hydroxyindole and l-serine, which are less cost-intensive substrates, compared to the previous method. Furthermore, we show enzymatic production of 7-phosphoryloxytryptamine (isonorbaeocystin), a non-natural congener of the Psilocybe alkaloid norbaeocystin (4-phosphoryloxytryptamine), and of serotonin (5-hydroxytryptamine) by means of the same in vitro approach.

Mutagenesis of an Active-Site Loop in Tryptophan Hydroxylase Dramatically Slows the Formation of an Early Intermediate in Catalysis

Subedi, Bishnu P.,Fitzpatrick, Paul F.

supporting information, p. 5185 - 5192 (2018/04/23)

Solution studies of the aromatic amino acid hydroxylases are consistent with the FeIVO intermediate not forming until both the amino acid and tetrahydropterin substrates have bound. Structural studies have shown that the positions of active-site loops differs significantly between the free enzyme and the enzyme-amino acid-tetrahydropterin complex. In tryptophan hydroxylase (TrpH) these mobile loops contain residues 124-134 and 365-371, with a key interaction involving Ile366. The I366N mutation in TrpH results in decreases of 1-2 orders of magnitude in the kcat and kcat/Km values. Single turnover analyses establish that the limiting rate constant for turnover is product release for the wild-type enzyme but is formation of the first detectable intermediate I in catalysis in the mutant enzyme. The mutation does not alter the kinetics of NO binding to the ternary complex nor does it uncouple FeIVO formation from amino acid hydroxylation. The effects on the kcat value of wild-type TrpH of changing viscosity are consistent with rate-limiting product release. While the effect of viscosity on the kcat/KO2 value is small, consistent with reversible oxygen binding, the effects on the kcat/Km values for tryptophan and the tetrahydropterin are large, with the latter value exceeding the expected limit and varying with the identity of the viscogen. In contrast, the kinetic parameters of I366N TrpH show small changes with viscosity. The results are consistent with binding of the amino acid and pterin substrate to form the ternary complex being directly coupled to closure of loops over the active site and formation of the reactive complex. The mutation destabilizes this initial event.

A Panel of TrpB Biocatalysts Derived from Tryptophan Synthase through the Transfer of Mutations that Mimic Allosteric Activation

Murciano-Calles, Javier,Romney, David K.,Brinkmann-Chen, Sabine,Buller, Andrew R.,Arnold, Frances H.

supporting information, p. 11577 - 11581 (2016/10/24)

Naturally occurring enzyme homologues often display highly divergent activity with non-natural substrates. Exploiting this diversity with enzymes engineered for new or altered function, however, is laborious because the engineering must be replicated for each homologue. A small set of mutations of the tryptophan synthase β-subunit (TrpB) from Pyrococcus furiosus, which mimics the activation afforded by binding of the α-subunit, was demonstrated to have a similar activating effect in different TrpB homologues with as little as 57 % sequence identity. Kinetic and spectroscopic analyses indicate that the mutations function through the same mechanism: mimicry of α-subunit binding. From these enzymes, we identified a new TrpB catalyst that displays a remarkably broad activity profile in the synthesis of 5-substituted tryptophans. This demonstrates that allosteric activation can be recapitulated throughout a protein family to explore natural sequence diversity for desirable biocatalytic transformations.

Regioselective enzymatic halogenation of substituted tryptophan derivatives using the FAD-dependent halogenase RebH

Frese, Marcel,Guzowska, Paulina H.,Voss, Hauke,Sewald, Norbert

, p. 1270 - 1276 (2014/05/20)

Regioselective methods to establish carbon-halide bonds are still rare, although halogenation is considered as a commonly used methodology for the functionalization of organic compounds. The incorporation of halogen substituents by organic synthesis usually requires hazardous conditions, shows poor regioselectivity and results in the formation of unwanted byproducts. In addition, halogenation by electrophilic aromatic substitution (SEAr) obeys distinct rules depending on electron-withdrawing or -donating groups already present in the aromatic ring. We employed the tryptophan-7-halogenase RebH for regioselective enzymatic halogenation to overcome these limitations. In combination with a tryptophan synthase, an array of C5- and C6-substituted tryptophan derivatives was synthesized and halogenated by RebH. The halogenase is able override these directing effects and halogenates at the electronically unfavored C7-meta-position, even in presence of ortho/para-directing groups. No business as usual: The tryptophan halogenase RebH from Lechevalieria aerocolonigenes is able to halogenate at the electronically unfavored C7-meta-position of C5-substituted tryptophan derivatives, even in presence of deactivating ortho/para-directing groups.

Similarities and differences of serotonin and its precursors in their interactions with model membranes studied by molecular dynamics simulation

Wood, Irene,Martini, M. Florencia,Pickholz, Mónica

, p. 124 - 130 (2013/07/27)

In this work, we report a molecular dynamics (MD) simulations study of relevant biological molecules as serotonin (neutral and protonated) and its precursors, tryptophan and 5-hydroxy-tryptophan, in a fully hydrated bilayer of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidyl-choline (POPC). The simulations were carried out at the fluid lamellar phase of POPC at constant pressure and temperature conditions. Two guest molecules of each type were initially placed at the water phase. We have analyzed, the main localization, preferential orientation and specific interactions of the guest molecules within the bilayer. During the simulation run, the four molecules were preferentially found at the water-lipid interphase. We found that the interactions that stabilized the systems are essentially hydrogen bonds, salt bridges and cation-π. None of the guest molecules have access to the hydrophobic region of the bilayer. Besides, zwitterionic molecules have access to the water phase, while protonated serotonin is anchored in the interphase. Even taking into account that these simulations were done using a model membrane, our results suggest that the studied molecules could not cross the blood brain barrier by diffusion. These results are in good agreement with works that show that serotonin and Trp do not cross the BBB by simple diffusion.

TRP/HIS EXCHANGE AND KYNURENIN INDUCED TRP TRANSPORT

-

, (2011/10/04)

The present invention provides methods for detecting changes in tryptophan concentrations in a cell and methods for identifying agents that modulate cellular tryptophan concentrations. In particular, the present invention provides methods for detecting cellular exchange between tryptophan and kynurenine, and methods for identifying agents that modulate this exchange. The present invention also provides methods for treating a disease associated with immunosuppression in a subject in need thereof. In particular, the present invention is directed toward a method of treating a disease associated with immunosuppression comprising contacting the disease with an agent that modulates cellular Trp/kynurenine exchange. Furthermore, the present invention provides methods for identifying an agent that modulates an immunosuppression.

Plant phenolics affect oxidation of tryptophan

Salminen, Hanna,Heinonen, Marina

experimental part, p. 7472 - 7481 (2010/04/29)

The effect of berry phenolics such as anthocyanins, ellagitannins, and proanthocyanidins from raspberry (Rubus idaeus), black currant (Ribes nigrum), and cranberry (Vaccinium oxycoccus) and byproducts of deoiling processes rich in phenolics such as rapese

Chemo-enzymatic synthesis and characterization of L-tryptophans selectively 13C-enriched or hydroxylated in the six-membered ring using transformed Escherichia coli cells

Berg, E. M. M. van den,Jansen, F. J. H. M.,Goede, A. T. J. W. de,Baldew, A. U.,Lugtenburg, J.

, p. 287 - 297 (2007/10/02)

L-(3a-13C)- and L-(6-13C)tryptophan have been synthesized from simple labelled compounds via a single reaction scheme based on the conversion of 1,3-cyclohexanedione into indole.The labelled indoles have been converted in one step into the corresponding L-tryptophans using transformed Escherichia coli cells with large amounts of the enzyme, tryptophan synthease.The same reaction scheme has been used for the synthesis of 4- and 7-indolol.These hydroxyindoles together with 5-indolol have been converted into 4-, 7- and 5-hydroxy-L-tryptophan, respectively, using theEscherichia coli cells.The latter compound is the immediate precursor of the neurotransmitter, serotonin.It appears that 7-indolol is the only indole derivative which is converted faster than unsubstituted indole by the enzyme, tryptophan synthease.With the preparation of L-(3a-13C)- and L-(6-13C)tryptophan, we have completed the series of indoles and L-tryptophans with a stable isotope (13C, 15N or 2H) in the aromatic ring.In this paper, we also discuss the NMR parameters of these mono-isotopically labelled systems.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4350-09-8